Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Colorcon
Medtronic
Chubb
US Army
Express Scripts
Baxter
UBS
McKesson

Generated: June 20, 2018

DrugPatentWatch Database Preview

LITHOSTAT Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Lithostat patents expire, and when can generic versions of Lithostat launch?

Lithostat is a drug marketed by Mission Pharma and is included in one NDA.

The generic ingredient in LITHOSTAT is acetohydroxamic acid. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the acetohydroxamic acid profile page.
Drug patent expirations by year for LITHOSTAT
Pharmacology for LITHOSTAT
Drug ClassUrease Inhibitor
Mechanism of ActionUrease Inhibitors
Synonyms for LITHOSTAT
46A883
4RZ82L2GY5
546-88-3
A0051
A830321
AB00051907_07
AB0010594
AB01014
AC1L1COH
AC1Q1L7G
Acetamide, N-hydroxy-
Acetamide, N-hydroxy- (9CI)
Acetamide, N-hydroxy-(9CI)
Acethydroxamic acid
Acethydroxamsaeure
Acethydroxamsaeure [German]
Acethydroxamsaure
acethydroximic acid
acetic acid oxime
Acetic acid, oxime
Acetic acid|oxime
Acetohydroxamate
acetohydroxamic acid
ACETOHYDROXAMIC ACID (AHA)
Acetohydroxamic acid (USP/INN)
Acetohydroxamic acid [USAN:INN]
Acetohydroxamic acid [USAN:USP:INN]
Acetohydroxamic acid, 98%
Acetohydroxamic acid, 98% 1g
Acetohydroxamic acid, United States Pharmacopeia (USP) Reference Standard
ACETOHYDROXAMICACID
acetohydroxamsaure
acetohydroxarnic acid
Acetohydroximic acid
Acetohyroxamic acid
Acetyl hydroxyamine
Acetyl hydroxyamino
Acetylhydroxamic acid
ACETYLHYDROXYLAMINE
Acide acetohydroxamique
Acide acetohydroxamique [French]
Acido acetohidroxamico
Acido acetohidroxamico [Spanish]
Acidum acetohydroxamicum
Acidum acetohydroxamicum [Latin]
ACMC-1AWJW
ACN-S002461
ACT05768
AHA
AHA (TN)
AI3-62232
AJ-51852
AK-43984
AKOS000172340
AKOS025395628
AM20100343
AN-21371
ANW-32160
BDBM50099857
BP-13320
BR-43984
BSPBio_001790
C06808
CA0112
CAS-546-88-3
CCG-38927
CCRIS 1730
cetohyroxamic acid
CH3C(O)NHOH
CHEBI:27777
CHEBI:49029
CHEMBL734
CJ-12199
CS-4881
CTK1G9446
CTK8A6224
D00220
D0R9BG
DB-052632
DB00551
DivK1c_000821
DSSTox_CID_2546
DSSTox_GSID_22546
DSSTox_RID_76622
DTXSID7022546
EBD2201963
EINECS 208-913-8
EN300-36948
ethanehydroxamic acid
FT-0621796
HAE
HMS1920A07
HMS2091G07
HMS2231M17
HMS502J03
HSDB 3585
HY-B1235
Hydroxylamine, N-acetyl-
I08-0057
IDI1_000821
KB-47074
KBio1_000821
KBio2_000360
KBio2_002928
KBio2_005496
KBio3_001290
KBioGR_000556
KBioSS_000360
KS-00000UQU
KSC269I4N
Lithostat (TN)
LS-13067
M-3701
MCULE-2682231025
methyl hydroximic acid
Methylhydroxamic acid
MFCD00009994
MLS001076662
MolPort-001-769-610
MolPort-028-751-555
MolPort-039-010-525
N-Acetyl hydroxyacetamide
N-Acetylhydroxylamine
n-hydroxy-acetamide
N-Hydroxyacetamide
N-hydroxyacetimidic acid
N-hydroxyethanimidic acid
N-oxidanylethanamide
N-Oxylatoacetamide
NCGC00094576-01
NCGC00094576-02
NCGC00094576-03
NCGC00094576-05
NINDS_000821
NSC 176136
NSC-176136
NSC-5073
NSC-755855
NSC176136
NSC5073
NSC755855
OR000150
OR282809
Pharmakon1600-01500103
Prestwick_38
RRUDCFGSUDOHDG-UHFFFAOYSA-N
RTR-019336
S14-0751
s4602
SBI-0051270.P003
SC-18498
SJX HLdmMAH
sJX`HLdmMAH`
SMR000499570
SPBio_000098
Spectrum_000020
SPECTRUM1500103
Spectrum2_000109
Spectrum3_000285
Spectrum4_000138
Spectrum5_000812
ST24033130
Tox21_111301
Tox21_111301_1
TR-019336
UNII-4RZ82L2GY5
W-105609
WLN: QMV1
ZINC4658603
ZLC0003
zlchem 200

US Patents and Regulatory Information for LITHOSTAT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mission Pharma LITHOSTAT acetohydroxamic acid TABLET;ORAL 018749-001 May 31, 1983 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Healthtrust
Merck
US Army
Citi
McKinsey
Express Scripts
Cantor Fitzgerald
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.